Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy-Reference-Cited by-同舟云学术

Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy

Published:2011-01-26 Issue:6 Volume:46 Page:758-768
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Tanaka Naoki,Horiuchi Akira,Yokoyama Takahide,Kaneko Gengo,Horigome Naoto,Yamaura Takahiro,Nagaya Tadanobu,Komatsu Michiharu,Sano Kenji,Miyagawa Shin-ichi,Aoyama Toshifumi,Tanaka Eiji

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-011-0370-5.pdf

Reference29 articles.

1. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008;48:S104–12.

2. Ono M, Saibara T. Clinical features of nonalcoholic steatohepatitis in Japan: evidence from the literature. J Gastroenterol. 2006;41:725–32.

3. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol. 2002;37:154–60.

4. Nagaya T, Tanaka N, Komatsu M, Ichijo T, Sano K, Horiuchi A, et al. Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case. Clin J Gastroenterol. 2008;1:116–21.

5. Dresler CM, Fortner JG, McDermott K, Bajorunas DR. Metabolic consequences of (regional) total pancreatectomy. Ann Surg. 1991;214:131–40.

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Significance and Risk Factors of Nonalcoholic Fatty Liver Diseases After Whipple Procedure;Journal of Surgical Research;2024-10

2. Rapid deterioration of steatotic liver disease due to portal vein stenosis after pancreaticoduodenectomy;Clinical Journal of Gastroenterology;2024-08-15

3. Cirrhosis after pancreaticoduodenectomy for pancreatic cancer;Hepatobiliary & Pancreatic Diseases International;2024-08

4. Exploring the potential of drug repurposing for liver diseases: A comprehensive study;Life Sciences;2024-06

5. Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy?;JGH Open;2024-06